Evidence map›Paper›PMID 41132002›Full record

ArticleActa oncologica (Stockholm, Sweden)2025

Integrating 2D dosimetry and cell survival analysis for predicting local effect in spatially fractionated radiotherapy.

Delmon Arous, Jacob Larsen Lie, Nina Frederike Jeppesen Edin, Eirik Malinen

Abstract read
In one paragraph

Article in Acta oncologica (Stockholm, Sweden), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Delmon ArousDepartment of Physics, University of Oslo, Norway; Department of Medical Physics, Oslo University Hospital, Norway. eirik.malinen@fys.uio.no.
Jacob Larsen LieDepartment of Physics, University of Oslo, Norway.
Nina Frederike Jeppesen EdinDepartment of Physics, University of Oslo, Norway.ORCID 0000-0002-6995-131X
Eirik MalinenDepartment of Physics, University of Oslo, Norway; Department of Radiation Biology, Oslo University Hospital, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeRobust methods for analysis and prediction of local cell survival after spatially fractionated radiotherapy (SFRT) in vitro remain limited. We present a methodology integrating spatial dosimetry with colony formation assessment and modelling to improve prediction of SFRT-induced responses. Patient/material and methods: A549 lung cancer cells were irradiated with 220 kV X-rays in three field patterns: open, striped, and dotted. Colony centroid locations were mapped from scanned images of culture flasks. Dose distributions were measured using radiochromic film dosimetry. Digital images with colony locations and dose maps were divided into 1 mm² quadrats. A Poisson regression model was fitted to colony counts per quadrat, incorporating linear-quadratic (LQ) model parameters α and β. A modified LQ (MLQ) model included an additional interaction between dose and nearest distance to a peak region, with parameter δ.

resultsThe methodology was successfully implemented. LQ fitting across all quadrats and patterns yielded α = 0.254 Gy-¹ and β = 0.039 Gy-², while the MLQ model gave α = 0.249 Gy-¹, β = 0.032 Gy-², and δ = -0.040 Gy-¹ cm-¹. Parameter uncertainty was below 0.5%. The MLQ model showed slightly lower fitting errors than the LQ model, indicating improved predictive accuracy.

interpretationWe introduce a novel analysis pipeline for 2D localization of colonies and SFRT survival modelling in vitro. Findings suggest that distance to peak dose regions significantly influences local SFRT effects. Incorporating this spatial factor via an MLQ model may enhance understanding and prediction of SFRT-induced survival.

Indexed as

Cell SurvivalDose Fractionation, RadiationLung NeoplasmsRadiometryA549 CellsHumans

Identifiers

PMID41132002
PMCPMC12573667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.